Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04539561
Other study ID # Focus-PiQo4 Pigmentation-19-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 24, 2020
Est. completion date April 2022

Study information

Verified date March 2021
Source Focus Medical, LLC
Contact Firas Al-Niaimi, MD
Phone +447956147543
Email Firas55@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A total of 20 healthy subjects at a single site, aged 21-70 years old with congenital or acquired challenging/resistant, age/sun-related flat and benign hand pigmentation who wish to improve their skin appearance.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date April 2022
Est. primary completion date April 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria: - Healthy Female/Male. - Age= 21-70 (Adults). - Fitzpatrick skin phototype = I-V - Congenital or acquired benign pigmentation on hands. - Presence of at least three (3) lesions with similar pigmentation intensity in the treatment area in diameters larger than 2 mm. - Able to read, understand and provide written Informed Consent. - Able and willing to comply with the treatment/follow-up schedule and requirements. - Women of child-bearing potential are required to use a reliable method of birth control (such as an intrauterine device, birth control pills, condom with spermicidal, NuvaRing, partner with vasectomy, Implanon or other FDA-approved devices, or abstinence) during the course of the study. Exclusion Criteria: - History of post inflammatory pigmentary disorders, particularly a tendency for hyper- or hypo-pigmentation. - Tanning (artificial or natural) 1 month prior first treatment and during the entire study duration including follow-up. - Excessive underlying vascular conditions (e.g. dense network of capillaries). - Pregnant, intending to become pregnant during the course of study, less than 3 months postpartum or less than 3 months after completion of breastfeeding. - Prior skin laser, light or other energy device treatment in treated area within 6 months of initial treatment or during the course of the study. - Prior ablative resurfacing procedure in treated area with laser or other devices within 12 months of initial treatment or during the course of the study. - Prior treatment with medium-depth or deeper, chemical peels or dermabrasion in treated area within 3 months of initial treatment or during the course of the study. - Any other surgery in treated area within 9 months of initial treatment or during the course of the study. - Hypersensitive to light exposure or the use of photosensitive medication for which light exposure is contraindicated. - Multiple dysplastic nevi or suspicious pigmentation in area to be treated. - Presence of underlying tattoo in the treatment area. - Significant concurrent illness (e.g. uncontrolled diabetes) or any disease state that in the opinion of the Investigator would interfere with the treatment or healing process.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PiQo4 Laser System
PiQo4 Laser System for treatment of hand pigmentation

Locations

Country Name City State
United Kingdom "Sk;N" Clinic London

Sponsors (1)

Lead Sponsor Collaborator
Focus Medical, LLC

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hands pigmentation change assessed by investigator Hands pigmentation change assessed by investigator at the 1 month follow up using the 5-point Pigment Improvement Score where score of between 0 and 4 will be assigned (0- No improvement in pigmentation, 1- Trace to mild improvement of some lesions, 2- Moderate response: some lesions lighter, 3- Good response: most lesions much lighter and 4- Excellent response- Most or all lesions much lighter or gone. 1 month follow up
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05913102 - A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin N/A
Completed NCT05750914 - Evaluation of Broadband Light Treatment for Pigmented Skin Lesions N/A
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Completed NCT05662592 - Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Enrolling by invitation NCT01847066 - Epidermal Delivery of Ani-Aging Ingredients N/A
Completed NCT03065582 - The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects N/A
Completed NCT03565146 - Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions N/A
Completed NCT04493021 - Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions N/A
Terminated NCT02506101 - Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo N/A
Not yet recruiting NCT05160103 - 16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects N/A
Completed NCT06075641 - Post Gingival Depigmentation Assessment: Comparison of Surgical Stripping vs (Er,Cr:YSGG) Laser N/A
Completed NCT01885091 - Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage Phase 4
Completed NCT05710068 - Effects of RF Microneedle on Photoaging Skin N/A
Completed NCT05304624 - Comparison of Er,Cr:YSGG Laser and Diode Laser in the Treatment of Gingival Melanin Pigmentation N/A
Recruiting NCT04865094 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure N/A
Recruiting NCT04866797 - Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure N/A
Completed NCT04881058 - Post Market Clinical Follow Up Study to Collect Additional Data and Imaging N/A
Completed NCT03970317 - Safety and Efficacy of Broad Band Light In Motion Treatment N/A